Invention Grant
- Patent Title: Use of C1q/TNF-related protein-1 (CTRP1) to treat fatty liver disease
-
Application No.: US16307241Application Date: 2017-06-08
-
Publication No.: US11213570B2Publication Date: 2022-01-04
- Inventor: Guang William Wong , Susana Rodriguez
- Applicant: THE JOHNS HOPKINS UNIVERSITY
- Applicant Address: US MD Baltimore
- Assignee: THE JOHNS HOPKINS UNIVERSITY
- Current Assignee: THE JOHNS HOPKINS UNIVERSITY
- Current Assignee Address: US MD Baltimore
- Agency: Johns Hopkins Technology Ventures
- International Application: PCT/US2017/036535 WO 20170608
- International Announcement: WO2017/214383 WO 20171214
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61K38/19 ; A61P1/16 ; A61K31/4402 ; A01K67/027
Abstract:
Methods for the treatment or prevention of disease, such as fatty liver disease and obesity, are described including the modulation the amount of CTRP1 in a subject. Novel mouse strains are also described.
Public/Granted literature
- US20190191676A1 USE OF C1Q/TNF-RELATED PROTEIN-1 (CTRP1) TO TREAT FATTY LIVER DISEASE Public/Granted day:2019-06-27
Information query
IPC分类:
